搡老女人多毛老妇女中国,日韩亚洲欧美中文高清在线,人妻少妇一区二区三区,色妞色综合久久夜夜,日本熟妇xxxx

Your Good Partner in Biology Research

重組蛋白

產(chǎn)品名稱 貨號(hào) 規(guī)格
Recombinant Shewanella halifaxensis 3-isopropylmalate dehydratase small subunit (leuD) CSB-YP532509SYU
CSB-EP532509SYU
CSB-BP532509SYU
CSB-MP532509SYU
CSB-EP532509SYU-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Shewanella halifaxensis Phosphate acyltransferase (plsX) CSB-YP532510SYU
CSB-EP532510SYU
CSB-BP532510SYU
CSB-MP532510SYU
CSB-EP532510SYU-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Shewanella halifaxensis UPF0234 protein Shal_3198 (Shal_3198) CSB-YP532511SYU
CSB-EP532511SYU
CSB-BP532511SYU
CSB-MP532511SYU
CSB-EP532511SYU-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Shewanella halifaxensis Probable rRNA maturation factor (Shal_3224) CSB-YP532512SYU
CSB-EP532512SYU
CSB-BP532512SYU
CSB-MP532512SYU
CSB-EP532512SYU-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Shewanella halifaxensis UPF0250 protein Shal_3239 (Shal_3239) CSB-YP532513SYU
CSB-EP532513SYU
CSB-BP532513SYU
CSB-MP532513SYU
CSB-EP532513SYU-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Shewanella halifaxensis Na (+)/H (+) antiporter nhaB, partial CSB-YP532514SYU
CSB-EP532514SYU
CSB-BP532514SYU
CSB-MP532514SYU
CSB-EP532514SYU-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Shewanella halifaxensis Catalase-peroxidase (katG), partial CSB-YP532515SYU
CSB-EP532515SYU
CSB-BP532515SYU
CSB-MP532515SYU
CSB-EP532515SYU-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Shewanella halifaxensis D-ribose pyranase (rbsD) CSB-YP532516SYU
CSB-EP532516SYU
CSB-BP532516SYU
CSB-MP532516SYU
CSB-EP532516SYU-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Shewanella halifaxensis tRNA (cmo5U34)-methyltransferase CSB-YP532517SYU
CSB-EP532517SYU
CSB-BP532517SYU
CSB-MP532517SYU
CSB-EP532517SYU-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Shewanella halifaxensis 7-cyano-7-deazaguanine synthase (queC) CSB-YP532518SYU
CSB-EP532518SYU
CSB-BP532518SYU
CSB-MP532518SYU
CSB-EP532518SYU-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Shewanella halifaxensis Aspartate carbamoyltransferase 2 (pyrB2) CSB-YP532519SYU
CSB-EP532519SYU
CSB-BP532519SYU
CSB-MP532519SYU
CSB-EP532519SYU-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Shewanella halifaxensis 3-demethylubiquinone-9 3-methyltransferase (ubiG) CSB-YP532520SYU
CSB-EP532520SYU
CSB-BP532520SYU
CSB-MP532520SYU
CSB-EP532520SYU-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Shewanella halifaxensis 3-phosphoshikimate 1-carboxyvinyltransferase (aroA) CSB-YP532521SYU
CSB-EP532521SYU
CSB-BP532521SYU
CSB-MP532521SYU
CSB-EP532521SYU-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Shewanella halifaxensis Sulfite reductase [NADPH] hemoprotein beta-component (cysI), partial CSB-YP532522SYU
CSB-EP532522SYU
CSB-BP532522SYU
CSB-MP532522SYU
CSB-EP532522SYU-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Shewanella halifaxensis Fructose-1,6-bisphosphatase class 1 (fbp) CSB-YP532523SYU
CSB-EP532523SYU
CSB-BP532523SYU
CSB-MP532523SYU
CSB-EP532523SYU-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Shewanella halifaxensis D-erythrose-4-phosphate dehydrogenase (epd) CSB-YP532524SYU
CSB-EP532524SYU
CSB-BP532524SYU
CSB-MP532524SYU
CSB-EP532524SYU-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Shewanella halifaxensis Outer-membrane lipoprotein carrier protein (lolA) CSB-YP532525SYU
CSB-EP532525SYU
CSB-BP532525SYU
CSB-MP532525SYU
CSB-EP532525SYU-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Shewanella halifaxensis Asparagine--tRNA ligase (asnS) CSB-YP532526SYU
CSB-EP532526SYU
CSB-BP532526SYU
CSB-MP532526SYU
CSB-EP532526SYU-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Shewanella halifaxensis UDP-N-acetylglucosamine 1-carboxyvinyltransferase (murA) CSB-YP532527SYU
CSB-EP532527SYU
CSB-BP532527SYU
CSB-MP532527SYU
CSB-EP532527SYU-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Shewanella halifaxensis 50S ribosomal protein L31 (rpmE) CSB-YP532528SYU
CSB-EP532528SYU
CSB-BP532528SYU
CSB-MP532528SYU
CSB-EP532528SYU-B
20μg/100μg/1mg(1mg*1 or 500ug*2)

有用資源

什么是重組蛋白?

重組蛋白是一種可操縱的蛋白質(zhì)形式,可以通過多種方式產(chǎn)生大量蛋白質(zhì)、修改基因序列和制造有用的商業(yè)產(chǎn)品。重組蛋白的技術(shù)資源在重組蛋白的開發(fā)過程中,除了表達(dá)系統(tǒng)之外,還面臨著一系列令人困惑的選擇,如表達(dá)載體的選擇、表達(dá)蛋白的長度(全長或部分)、是否帶標(biāo)簽等。在生產(chǎn)重組蛋白時(shí),你必須做出很多決定。如果你選擇的明智,你將獲得高質(zhì)量的重組蛋白,后續(xù)的實(shí)驗(yàn)更有可能成功。但是如果你做了錯(cuò)誤的決定,你可能得不到你所需要的重組蛋白或者重組蛋白的質(zhì)量和純度不符合要求。在這里,來自CUSABIO的蛋白表達(dá)工程師根據(jù)他們開發(fā)重組蛋白的經(jīng)驗(yàn)總結(jié)出了幾個(gè)有用的提示,可以幫助你做出明智的決策。

第一條:重組蛋白的生產(chǎn),在這篇文章中,我們旨在闡明重組蛋白的定義以及如何生產(chǎn)重組蛋白。

第二條:如何選擇合適的表達(dá)載體?

表達(dá)載體是一種DNA分子,它攜帶特定的基因進(jìn)入宿主細(xì)胞,并利用細(xì)胞的蛋白質(zhì)合成機(jī)制來產(chǎn)生由該基因編碼的蛋白質(zhì)。表達(dá)載體可使外源基因在宿主細(xì)胞中高效表達(dá),經(jīng)過多年的發(fā)展,表達(dá)載體已成為一種成熟而受歡迎的生物技術(shù)。在重組蛋白生產(chǎn)過程中是一種基本成分。正如標(biāo)題所示,本文主要總結(jié)了幾個(gè)有用的技巧來選擇合適的表達(dá)載體。

第三條:如何表達(dá)具有生物活性的蛋白質(zhì)?

根據(jù)重組蛋白的不同應(yīng)用,對(duì)其生物活性有不同的要求。但是我們?nèi)绾未_保蛋白質(zhì)的產(chǎn)生具有生物活性呢?本文將圍繞這個(gè)主題,并提供一些解決方案。除了以上文章,我們還收集了一些重組蛋白的常見問題。您可以單擊以下鏈接查看。http://www.pptc.cn/technology-91.html。此外,我們還為我們的客戶提供重組蛋白表達(dá)服務(wù),您可以點(diǎn)擊這里獲取更多信息。注:如果您對(duì)CUSABIO的蛋白質(zhì)有任何疑問,涉及到蛋白質(zhì)的價(jià)格、交貨、質(zhì)量等,您可以點(diǎn)擊橙色按鈕為我們?cè)诰€留言。

引用資料

Recombinant Severe acute respiratory syndrome coronavirus 2 RNA-dependent RNA polymerase(NSP12) cited in "SARS-CoV-2 hijacks cellular kinase CDK2 to promote viral RNA synthesis". Signal transduction and targeted therapy, 2023

Recombinant Mouse Mixed lineage kinase domain-like protein(Mlkl) cited in "OASL phase condensation induces amyloid-like fibrillation of RIPK3 to promote virus-induced necroptosis". Nature cell biology, 2023

Recombinant Mouse Proto-oncogene c-Fos(Fos) cited in "Dihydroartemisinin imposes positive and negative regulation on Treg and plasma cells via direct interaction and activation of c-Fos". Communications biology, 2023

Recombinant Human Keratin, type I cytoskeletal 18(KRT18) cited in "Calcitonin gene-related peptide ameliorates sepsis-induced intestinal injury by suppressing NLRP3 inflammasome activation". International immunopharmacology, 2023

Recombinant Human Protein Wnt-5a (WNT5A) cited in "ATBF1 is a potential diagnostic marker of histological grade and functions via WNT5A in breast cancer". BMC Cancer, 2022

Read More >>